Erythropoietin induces the tyrosine phosphorylation of GAB1 and its association with SHC, SHP2, SHIP, and phosphatidylinositol 3-kinase.

Five tyrosine-phosphorylated proteins with molecular masses of 180, 145, 116, 100, and 70 kD are associated with phosphatidylinositol 3-kinase (PI 3-kinase) in erythropoietin (Epo)-stimulated UT-7 cells. The 180- and 70-kD proteins have been previously shown to be IRS2 and the Epo receptor. In this report, we show that the 116-kD protein is the IRS2-related molecular adapter, GAB1. Indeed, Epo induced the transient tyrosine phosphorylation of GAB1 in UT-7 cells. Both kinetics and Epo dose-response experiments showed that GAB1 tyrosine phosphorylation was a direct consequence of Epo receptor activation. After tyrosine phosphorylation, GAB1 associated with the PI 3-kinase, the phosphotyrosine phosphatase SHP2, the phosphatidylinositol 3,4,5 trisphosphate 5-phosphatase SHIP, and the molecular adapter SHC. GAB1 was also associated with the molecular adapter GRB2 in unstimulated cells, and this association dramatically increased after Epo stimulation. Thus, GAB1 could be a scaffold protein able to couple the Epo receptor activation with the stimulation of several intracellular signaling pathways. Epo-induced tyrosine phosphorylation of GAB1 was also observed in normal human erythroid progenitors isolated from cord blood. Granulocyte-macrophage colony-stimulating factor (GM-CSF) and thrombopoietin (TPO) also induced the tyrosine phosphorylation of GAB1 in UT-7 cells, indicating that this molecule participates in the signal transduction of several cytokine receptors.

[1]  D. Parsell.  AAAS News & Notes , 2001, Science.

[2]  E. Van Obberghen,et al.  Determination of Gab1 (Grb2-associated binder-1) interaction with insulin receptor-signaling molecules. , 1998, Molecular endocrinology.

[3]  Keigo Nishida,et al.  Gab1 Acts as an Adapter Molecule Linking the Cytokine Receptor gp130 to ERK Mitogen-Activated Protein Kinase , 1998, Molecular and Cellular Biology.

[4]  G. Daley,et al.  Control of hematopoietic differentiation: lack of specificity in signaling by cytokine receptors. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[5]  G. Krystal,et al.  Targeted disruption of SHIP leads to hemopoietic perturbations, lung pathology, and a shortened life span. , 1998, Genes & development.

[6]  A. Bardelli,et al.  Gab1 coupling to the HGF/Met receptor multifunctional docking site requires binding of Grb2 and correlates with the transforming potential , 1997, Oncogene.

[7]  A. Wong,et al.  Grb2-associated binder-1 mediates phosphatidylinositol 3-kinase activation and the promotion of cell survival by nerve growth factor. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[8]  L. Peso,et al.  Interleukin-3-induced phosphorylation of BAD through the protein kinase Akt. , 1997, Science.

[9]  C. Lacombe,et al.  Erythropoietin Induces the Tyrosine Phosphorylation of Insulin Receptor Substrate-2 , 1997, The Journal of Biological Chemistry.

[10]  S. R. Datta,et al.  Akt Phosphorylation of BAD Couples Survival Signals to the Cell-Intrinsic Death Machinery , 1997, Cell.

[11]  M. Tremblay,et al.  Association of the Multisubstrate Docking Protein Gab1 with the Hepatocyte Growth Factor Receptor Requires a Functional Grb2 Binding Site Involving Tyrosine 1356* , 1997, The Journal of Biological Chemistry.

[12]  D. Kamikura,et al.  Efficient Cellular Transformation by the Met Oncoprotein Requires a Functional Grb2 Binding Site and Correlates with Phosphorylation of the Grb2-associated Proteins, Cbl and Gab1* , 1997, The Journal of Biological Chemistry.

[13]  H. Iwasaki,et al.  Role of the vav Proto-oncogene Product (Vav) in Erythropoietin-mediated Cell Proliferation and Phosphatidylinositol 3-Kinase Activity* , 1997, The Journal of Biological Chemistry.

[14]  H. Lodish,et al.  Identification of a novel pathway important for proliferation and differentiation of primary erythroid progenitors. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[15]  Lewis C Cantley,et al.  PI3K: Downstream AKTion Blocks Apoptosis , 1997, Cell.

[16]  David R. Kaplan,et al.  Direct Regulation of the Akt Proto-Oncogene Product by Phosphatidylinositol-3,4-bisphosphate , 1997, Science.

[17]  W. Birchmeier,et al.  Interaction between Gab1 and the c-Met receptor tyrosine kinase is responsible for epithelial morphogenesis , 1996, Nature.

[18]  G. Krystal,et al.  Early events in erythropoietin-induced signaling. , 1996, Experimental hematology.

[19]  I. Dusanter-Fourt,et al.  Functional regions of the mouse thrombopoietin receptor cytoplasmic domain: evidence for a critical region which is involved in differentiation and can be complemented by erythropoietin , 1996, Molecular and cellular biology.

[20]  A. Godwin,et al.  A Grb2-associated docking protein in EGF- and insulin-receptor signalling , 1996, Nature.

[21]  Rudolf Jaenisch,et al.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor , 1995, Cell.

[22]  G. Krystal,et al.  Phosphorylation of Tyrosine 503 in the Erythropoietin Receptor (EpR) Is Essential for Binding the P85 Subunit of Phosphatidylinositol (PI) 3-Kinase and for EpR-associated PI 3-Kinase Activity (*) , 1995, The Journal of Biological Chemistry.

[23]  I. Dusanter-Fourt,et al.  Tyrosine phosphorylation of the erythropoietin receptor: role for differentiation and mitogenic signal transduction. , 1995, Blood.

[24]  M. White,et al.  Regulation of Phosphatidylinositol 3′-Kinase by Tyrosyl Phosphoproteins , 1995, The Journal of Biological Chemistry.

[25]  L. Cantley,et al.  Phosphatidylinositol 3‐kinase , 1994, BioEssays : news and reviews in molecular, cellular and developmental biology.

[26]  N. Aoki,et al.  Erythropoietin-dependent association of phosphatidylinositol 3-kinase with tyrosine-phosphorylated erythropoietin receptor. , 1994, The Journal of biological chemistry.

[27]  M. Waterfield,et al.  Association of the p85 regulatory subunit of phosphatidylinositol 3-kinase with an essential erythropoietin receptor subdomain. , 1993, Blood.

[28]  W. Vainchenker,et al.  Erythropoietin induces the association of phosphatidylinositol 3'-kinase with a tyrosine-phosphorylated protein complex containing the erythropoietin receptor. , 1993, European journal of biochemistry.

[29]  O. Silvennoinen,et al.  JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin , 1993, Cell.

[30]  T. Pawson,et al.  Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor. , 1993, Blood.

[31]  A. de la Chapelle,et al.  Truncated erythropoietin receptor causes dominantly inherited benign human erythrocytosis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.

[32]  T. Pawson,et al.  SH2 domains recognize specific phosphopeptide sequences , 1993, Cell.

[33]  W. Vainchenker,et al.  Granulocyte-macrophage colony-stimulating factor and erythropoietin act competitively to induce two different programs of differentiation in the human pluripotent cell line UT-7. , 1992, Blood.

[34]  A. Mui,et al.  Erythropoietin-induced tyrosine phosphorylations in a high erythropoietin receptor-expressing lymphoid cell line. , 1992, Blood.

[35]  N. Casadevall,et al.  Erythropoietin induces the tyrosine phosphorylation of its own receptor in human erythropoietin-responsive cells. , 1992, The Journal of biological chemistry.

[36]  H. Lodish,et al.  In vitro phosphorylation of the erythropoietin receptor and an associated protein, pp130 , 1992, Molecular and cellular biology.

[37]  J. Ihle,et al.  Induction of tyrosine phosphorylation by the erythropoietin receptor correlates with mitogenesis , 1991, Molecular and cellular biology.

[38]  H. Nakauchi,et al.  Establishment and characterization of a human leukemic cell line with megakaryocytic features: dependency on granulocyte-macrophage colony-stimulating factor, interleukin 3, or erythropoietin for growth and survival. , 1991, Cancer research.

[39]  H. Lodish,et al.  Expression cloning of the murine erythropoietin receptor , 1989, Cell.